IP Library Granted Patent US 10,299,918
Granted Patent B2
US 10,299,918 · App. 15/423,368 · Granted May 28, 2019

Vena-caval device

Inventor: Yosi Tuval (Even Yehuda, IL)
Assignee: MAGENTA MEDICAL LTD.
A61F2/2418A61F2/82A61F2/856A61F2/2436A61F2/91A61F2/966A61F2002/821A61F2002/8483A61F2002/8486A61F2230/005A61F2230/0054A61F2230/0067A61F2250/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,299,918
App. No.
15/423,368
Granted
May 28, 2019
Kind
B2
Abstract

Apparatus and method are described including identifying a subject as suffering from a condition that causes the subject to have elevated central venous pressure. In response thereto, a device is placed inside the subject's vena cava such that an upstream end of the device is placed at a location upstream of junctions of the vena cava with all of the subject's renal veins. The device defines a passage through the device, at least a portion of the passage converging in a direction from an upstream end of the device to downstream end of the device. Other applications are also described.

Claims (13)

1. A method for use with renal veins and a vena cava of a subject, the method comprising:

identifying the subject as suffering from a condition that causes the subject to have elevated central venous pressure; and

in response thereto, reducing blood pressure within the subject's renal veins relative to the subject's central venous pressure, by directing antegrade blood flow through the subject's vena cava past the subject's renal veins, by placing a nozzle inside the subject's vena cava, such that an upstream end of the nozzle is placed at a location upstream of junctions of the vena cava with one or more of the subject's renal veins, the nozzle converging from the upstream end of the nozzle to a downstream end of the nozzle.

2. The method according to claim 1 , further comprising placing an additional device within the vena cava at a location that is downstream of the junctions of the vena cava with one or more of the subject's renal veins, the additional device being configured to direct blood flow through the vena cava in an antegrade direction.

3. The method according to claim 2 , wherein placing the additional device within the vena cava downstream of the junctions of the vena cava with one or more of the subject's renal veins comprises placing a valve inside the subject's vena cava at the location that is downstream of the junctions of the vena cava with one or more the subject's renal veins, the valve being configured to allow antegrade blood flow therethrough and to prevent retrograde blood flow therethrough.

4. A method for use with renal veins and a vena cava of a subject, the method comprising:

identifying a subject as suffering from a condition that causes the subject to have elevated central venous pressure; and

in response thereto, placing a device inside the vena cava such that an upstream end of the device is placed at a location upstream of junctions of the vena cava with one or more of the subject's renal veins, the device defining a passage through the device, at least a portion of the passage converging in a direction from the upstream end of the device to downstream end of the device.

5. The method according to claim 4 , wherein placing the device inside the vena cava such that the upstream end of the device is placed at the location upstream of junctions of the vena cava with one or more of the subject's renal veins comprises placing a nozzle inside the vena cava such that an upstream end of the nozzle is placed at the location upstream of junctions of the vena cava with one or more of the subject's renal veins.

6. The method according to claim 4 , further comprising placing an additional device within the vena cava at a location that is downstream of the junctions of the vena cava with one or more of the subject's renal veins, the additional device being configured to direct blood flow through the vena cava in an antegrade direction.

7. The method according to claim 6 , wherein placing the device inside the vena cava such that the upstream end of the device is placed at the location upstream of junctions of the vena cava with one or more of the subject's renal veins comprises placing a nozzle inside the vena cava such that the upstream end of the device is placed at the location upstream of junctions of the vena cava with one or more of the subject's renal veins.

8. The method according to claim 6 , wherein placing the additional device within the vena cava downstream of the junctions of the vena cava with one or more of the subject's renal veins comprises placing a valve inside the subject's vena cava at the location that is downstream of the junctions of the vena cava with the subject's renal veins, the valve being configured to allow antegrade blood flow therethrough and to prevent retrograde blood flow therethrough.

9. The method according to claim 8 , wherein placing the device inside the vena cava such that the upstream end of the device is placed at the location upstream of junctions of the vena cava with one or more of the subject's renal veins comprises placing a nozzle inside the vena cava such that the upstream end of the device is placed at the location upstream of junctions of the vena cava with one or more of the subject's renal veins.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2017
From: TUVAL, YOSI
To: MAGENTA MEDICAL LTD.
Reel/Frame 041162/0409 →
Continuity (3)
Continuation 14405144
Provisional Application 61656244 · Jun 6, 2012
Related Publication 20170143483A1 · May 25, 2017
Cited By (7)
US 12,390,631 US 12,414,851 US 12,491,062 US 12,569,251 US 12,594,416 US 12,629,509 US 12,728,256